Despite momentous improvements in perinatal care over the past few decades, retinopathy of prematurity (ROP) remains an interdisciplinary challenge for neonatologists and pediatric ophthalmologists. In the USA, treatment-warranted ROP increased from 3.4% to 5.3% between 2009 and 2018 among infants of 30 weeks gestation or less at birth. 1 In the international Vermont Oxford Network data, the median prevalence of severe ROP declined from 9% in 2005 to 6% in 2011, but has not further declined during the years 2011 to 2014. 2 In 2010, an estimated 185 000 infants born preterm developed any ROP and 20 000 subsequently suffered severe visual impairment or blindness. 3 In this review, our goal is to provide an overview of recent developments in our thinking about etiology, pathogenesis, diagnosis, intervention, and outcomes of ROP. Our aim is not to give an exhaustive overview, but to concentrate on novel ideas and findings. Reference to previous reviews is made where appropriate.The incidence of ROP decreases with increasing gestational age at birth, and it occurs mainly, but not exclusively, among infants born extremely preterm (<28 weeks gestational age) in high-income countries. A 'third epidemic' of ROP, however, is ongoing in low-and middle-income countries; here, the majority of infants with severe ROP appear to be more than 29 weeks gestational age. 4 [Correction added on 5 December 2022 after first online publication: In the sentence ''A 'third epidemic' … be more than 29 weeks gestational age'', the word 'less' was updated to 'more'.] The phenotype and disease trajectory in these more mature infants differ appreciably from that in infants born extremely preterm, which comes with its own set of difficulties regarding screening and intervention.ROP is a developmental disorder in that the clinical picture changes over the course of the neonatal and postneonatal periods. In essence, the underlying developmental process of typical retinal vascularization is affected in different ways at different time-points. 5 Clinically, the predominant feature of the disorder is abnormal retinal vascular development, beginning with a first phase of retinal vessel development cessation or delay shortly after birth that is exacerbated during the ensuing